# Pioglitazone on Pancreatic Steatosis and Bone Health

> **NCT00855010** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 42 (actual)

## Conditions studied

- Obesity
- Type 2 Diabetes

## Interventions

- **DRUG:** pioglitazone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00855010
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855010, "Pioglitazone on Pancreatic Steatosis and Bone Health". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00855010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*